Dolby Laboratories (NYSE:DLB) Given Outperform Rating at Barrington Research

Posted by Stanley Muller on Jun 15th, 2026

Dolby Laboratories (NYSE:DLB – Get Free Report)‘s stock had its “outperform” rating restated by analysts at Barrington Research in a report released on Monday,Benzinga reports. They presently have a $90.00 price target on the electronics maker’s stock. Barrington Research’s price objective would suggest a potential upside of 71.13% from the stock’s current price.

A number of other brokerages have also commented on DLB. Rosenblatt Securities restated a “buy” rating and issued a $85.00 target price on shares of Dolby Laboratories in a research note on Thursday. Wall Street Zen upgraded Dolby Laboratories from a “hold” rating to a “buy” rating in a research note on Saturday, May 30th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Friday, March 27th. Three analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $90.75.

Get Our Latest Stock Analysis on Dolby Laboratories

Dolby Laboratories Trading Up 0.1%

Shares of NYSE DLB opened at $52.59 on Monday. The business has a fifty day simple moving average of $58.38 and a 200 day simple moving average of $62.17. The firm has a market capitalization of $4.98 billion, a price-to-earnings ratio of 20.79 and a beta of 0.81. Dolby Laboratories has a one year low of $51.78 and a one year high of $77.00.

Dolby Laboratories (NYSE:DLB – Get Free Report) last issued its earnings results on Thursday, April 30th. The electronics maker reported $1.37 EPS for the quarter, beating analysts’ consensus estimates of $1.31 by $0.06. The business had revenue of $395.63 million during the quarter, compared to analyst estimates of $385.80 million. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.Dolby Laboratories’s revenue was up 7.0% on a year-over-year basis. During the same period in the prior year, the company posted $1.34 earnings per share. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. On average, research analysts anticipate that Dolby Laboratories will post 3.21 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, SVP Shriram Revankar sold 3,000 shares of the firm’s stock in a transaction on Friday, May 15th. The stock was sold at an average price of $54.90, for a total value of $164,700.00. Following the completion of the sale, the senior vice president directly owned 80,603 shares in the company, valued at approximately $4,425,104.70. This trade represents a 3.59% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, SVP John D. Couling sold 7,666 shares of the firm’s stock in a transaction on Monday, June 1st. The shares were sold at an average price of $55.62, for a total value of $426,382.92. Following the completion of the sale, the senior vice president owned 118,727 shares of the company’s stock, valued at approximately $6,603,595.74. This trade represents a 6.07% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 39,791 shares of company stock valued at $2,231,653. 37.93% of the stock is owned by insiders.

Institutional Trading of Dolby Laboratories

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Edgestream Partners L.P. increased its stake in shares of Dolby Laboratories by 232.8% in the first quarter. Edgestream Partners L.P. now owns 22,376 shares of the electronics maker’s stock valued at $1,344,000 after buying an additional 15,652 shares in the last quarter. Amundi acquired a new stake in shares of Dolby Laboratories in the first quarter valued at $280,000. California State Teachers Retirement System increased its stake in shares of Dolby Laboratories by 24.5% in the first quarter. California State Teachers Retirement System now owns 72,518 shares of the electronics maker’s stock valued at $4,355,000 after buying an additional 14,270 shares in the last quarter. Quantinno Capital Management LP increased its stake in shares of Dolby Laboratories by 23.0% in the first quarter. Quantinno Capital Management LP now owns 58,316 shares of the electronics maker’s stock valued at $3,503,000 after buying an additional 10,887 shares in the last quarter. Finally, Entropy Technologies LP acquired a new stake in shares of Dolby Laboratories in the first quarter valued at $1,674,000. 58.56% of the stock is currently owned by institutional investors and hedge funds.

Dolby Laboratories Company Profile

(Get Free Report)

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.